Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity

Molecular Brain Research

Volumn 46, Issue 1-2, 1997, Pages 154-160

  Hom, Denise G ^a   Jiang, Dongmei ^a,b   Hong, Eun Jin ^a   Mo, Jun Qin ^a   Andersen, Julie K ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Dopaminergic; Glutathione peroxidase; MA; MPTP; PC12; ROS

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GLUTATHIONE PEROXIDASE; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL LOSS; CELL PROTECTION; CELL STRAIN; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; DRUG CYTOTOXICITY; DRUG TOXICITY; LIPID PEROXIDATION; NERVE ENDING; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE;

ANIMALS; CELL SURVIVAL; CLONE CELLS; DOPAMINE; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; METHAMPHETAMINE; MICE; MPTP POISONING; NEURONS; PC12 CELLS; RATS;

EID: 0342872019     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00296-3     Document Type: Article

References (44)

1. Adams, Jr., J.D., Klaidman, L.K. and Leung, A.-C., MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes, Free Rad. Biol. Med., 15 (1993) 181-186.
2. Ali, S.F., David, S.N., Newprot, G.D., Cadet, J.L. and Slikker, Jr., W., MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels, Synapse, 18 (1994) 27-34.
3. Andersen, J.K., Zhang, M.B., Zhong, X.H., Rosenberg, Y.Y. and Howard, B.D., 1-Methyl-4-phenyl-1,2,3,6-tetrahdropyridine resistant flat PC12 variants have a partial loss of transformed phenotype, J. Neurochem., 55 (1990) 559-567.
4. Andersen, J.K., Frim, D.M., Isacson, O. and Breakefield, X.O., Catecholaminergic cell atrophy in a transgenic mouse aberrantly overexpressing MAO-B in neurons, Neurodegeneration, 3 (1994) 97-109.
5. Beal, F., Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol., 31 (1992) 119-130.
6. Behl, C., Davis, J.B., Lesley, R. and Schubert, D., Hydrogen peroxide mediates amyloid β protein toxicity, Cell, 77 (1994) 817-827.
7. Ben-Shacher, D., Eschel, G., Riederer, P. and Youdim, M.B., Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implications for Parkinson's disease, Ann. Neurol., 32 (1992) S105-S110.
8. Cadet, J.L., Ali, S.F., Rothman, R.B. and Epstein, C.J., Neurotoxicity, drugs and abuse, and the CuZn-superoxide dismutase transgenic mice, Mol. Neurobiol., 11 (1995) 155-163.
9. Cadet, J.L., Sheng, P., Ali, S., Rothman, R., Carlson, E. and Epstein, C., Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice, J. Neurochem., 62 (1994) 380-383.
10. Chacon, J.N., Chedekel, M.R., Land, E.J. and Truscott, T.G., Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4 phenyl-pyridinium ion, Biochem. Biophys. Res. Commun., 144 (1987) 957-964.
11. Chiueh, C.C., Wu, R.M., Mohanakumar, K.P., Sternberger, L.M., Krishna, G., Obata, T. and Murphy, D.L., In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia, Ann. NY Acad. Sci., 738 (1994) 25-36.
12. Cho, A.K., Ice: a new dosage of an old drug, Science, 249 (1990) 631-634.
13. Cohen, G., Monoamine oxidase, hydrogen peroxide, and Parkinson's disease, Adv. Neurol., 45 (1986) 119-125.
14. Colton, C.A., Pagan, F., Snell, J., Colton, J.S., Cummins, A. and Gilbert, D.L., Protection from oxidation enhances the survival of mesencephalic neurons, Exp. Neurol., 132 (1995) 54-61.
15. Cortopassi, G. and Wang, E., Modeling the effects of age-related mtDNA mutation accumulation; complex I deficiency, superoxide, and cell death, Biochim. Biophys. Acta, 1271 (1995) 171-176.
16. Cubells, J.F., Rayport, S., Rajendran, G. and Sulzer, D., Methampetamine neurotoxicity involves vacualization of endocytic organelles and dopamine-dependent intracellular oxidative stress, J. Neurosci., 14 (1994) 2260-2271.
17. Dalmeida, V., Camarini, R., Azzalis, L.A., Mattei, R., Junqueira, V.B. and Carlini, E.A., Antioxidant defense in rat brain after chronic treatment with anorectic drugs, Toxicol. Lett., 81 (1995) 101-105.
18. Denton, T. and Howard, B.D., A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, J. Neurochem., 49 (1987) 622-630.
19. DeVito, M.J. and Wagner, G.C., Methamphetamine-induced neuronal damage: a possible role for free-radicals, Neuropharmacology, 28 (1989) 1145-1150.
20. Graham, D.G., Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease, Neurotoxicology, 5 (1984) 83-95.
21. Greene, L.A. and Rein, G., Release, storage, and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells, Brain Res., 129 (1977) 247-263.
22. Greene, L.A. and Tischler, A.S., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor, Proc. Natl. Acad. Sci. USA, 73 (1976) 2424-2428.
23. Hansen, M.B., Nielson, S.E. and Berg, K., Re-examination and further development of precise and rapid dye method for measuring cell gowth/cell killing, J. Immunol. Methods, 119 (1989) 203-210.
24. Heikkila, R.W., Sieber, B.A., Manzino, L. and Sonsalla, P.K., Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse, Mol. Chem. Neuropathol., 10 (1989) 171-181.
25. Hirsch, E.C., Why are catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? Ann. Neurol., 32 (1992) S88-S93.
26. Koh, J.Y. and Choi, D.W., Quantitative determination of glutamate mediated corticol neuronal injury in cell culture by lactate dehydrogenase efflux assay, J. Neurochem. Methods, 20 (1987) 83-90.
27. Lai, C.T., Zuo, D.M. and Yu, P.H., Is brain superoxide dismutase activity increased following chronic treatment with 1-deprenyl? J. Neural Transm., 41 (1994) 221-229.
28. Lawrence, R.A. and Burk, R.F., Glutathione peroxidase activity in selenium-deficient rat liver, Biochem. Biophy. Res. Commun., 71 (1976) 952-965.
29. Marongiu, M.E., Piccardi, M.P., Bernardi, F., Corsin, G.U. and Del Zompo, M., Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies, Neurosci. Lett., 94 (1988) 349-354.
30. Maue, R.A., Kraner, S.D., Goodman, R.H. and Mandel, G., Neuron-specific expression of the rat brain type II sodium channel gene is directed by upstream regulatory elements, Neuron, 4 (1990) 223-231.
31. Mo, J.-Q., Hom, D.G. and Andersen, J.K., Oxidative damage in aged mouse brain correlates with decreases in protective enzymes, Mech. Aging Dev., 81 (1995) 73-82.
32. Moscow, J.A., Morrow, C.S., He, R., Mullenbach, G.T. and Cowan, K.H., Structure and function of the 5′-flanking sequence of the human cytosolic selenium-dependent glutathione peroxidase gene (hgpx 1), J. Biol. Chem., 25 (1991) 5949-5958.
33. Przedborski, S., Kostic, V., Jackson-Lewis, V., Naini, A.B., Simonetti, S., Fahn, S., Carlson, E., Epstein, C.J. and Cadet, J.L., Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity, J. Neurosci., 12 (1992) 1658-1667.
34. Rebois, R.V., Reynolds, E.E., Toll, L. and Howard, B.D., Storage of dopamine and acetylcholine in granules of PC12, a clonal pheochromocytoma cell line, Biochemistry, 19 (1980) 1240-1248.
35. Singer, T.P., Castanoli, Jr., N., Ramsey, R.R. and Trevor, A.J., Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, J. Neurochem., 49 (1987) 1-8.
36. Sinha, B.K., Singh, Y. and Krishna, G., Formation of superoxide and hydroxyl radicals from 1 methyl-4-phenylpyridinium ion (MPP +): reductive activation by NADPH cytochrome P-450 reductase, Biochem. Biophys. Res. Commun., 135 (1986) 583-588.
37. Sofic, E., Paulus, W., Jellinger, K., Riederer, P. and Youdim, M.B., Selective increase of iron in substantia nigra zona compacta of parkinsonian brains, J. Neurochem., 56 (1991) 978-982.
38. Thiffault, C., Aumont, N., Quirion, R. and Poirier, J., Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain, J. Neurochem., 65 (1995) 2725-2733.
39. Wei, Q., Yeung, M., Jurma, O.P. and Andersen, J.K., Genetic elevation of monoamine oxidase levels in dopaminergic PC12 cells results in increased free radical damage and sensitivity to MPTP, J. Neurosci. Res. (in press).
40. Westlund, K.N., Denney, R.M., Kochersperger, L.M., Rose, R.M. and Abell, C.W., Distinct monoamine oxidase A and B populations in primate brain, Science, 230 (1985) 181-183.
41. Wilber, K.M., Bernheim, F. and Shapiro, O.W., The thiobarbituric acid test for the oxidation of unsaturated fatty acids by various agents, Arch. Biochem. Biophys., 24 (1949) 305-313.
42. Wu, R.M., Mohanakumar, K.P., Murphy, D.L. and Chiueh, C.C., Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline), Ann. NY Acad. Sci., 738 (1994) 214-221
43. Zaleska, M.M., Nagy, K. and Floyd, R.A., Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron, Neurochem. Res., 10 (1985) 397-410.
44. Zang, L.Y., Misra, H.P., Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, J. Biol. Chem., 268 (1993) 16504-16512.